The Senate effectively killed a bid to allow consumers to buy their prescription medicines abroad Monday, requiring U.S. officials to certify the safety and effectiveness of such drugs, which health officials have long said they cannot do. The pharmaceutical industry vehemently opposes allowing drug imports, arguing that they could leave the United States vulnerable to dangerous counterfeits, and the White House had threatened a veto as the Bush administration has long opposed prescription drug imports.
May 08, 2007 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
The Senate effectively killed a bid to allow consumers to buy their prescription medicines abroad Monday, requiring U.S. officials to certify the safety and effectiveness of such drugs.
The certification amendment, passed on a 49-40 vote, would require health officials to do something they have long said they cannot.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
**PLEASE READ THE COMPLETE AD BEFORE APPLYING***Established 25-year boutique Plaintiff's Personal Injury Law Firm in the Dadeland area seeki...
Our client, a multi-state full-service boutique, is seeking to add a senior construction litigation associate to their Florida team. Qualif...
